• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 传播风险筛查以确保社交活动更安全:一项非随机对照研究。

SARS-CoV-2 transmission risk screening for safer social events: a non-randomised controlled study.

机构信息

Vascular Health Research Group (ISV-Girona), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), c/ Maluquer Salvador, 11 baixos, 17002, Girona, Catalonia, Spain.

Department of Medical Sciences, School of Medicine, Campus Salut, Universitat de Girona, Girona, Catalonia, Spain.

出版信息

Sci Rep. 2022 Jul 27;12(1):12794. doi: 10.1038/s41598-022-16905-w.

DOI:10.1038/s41598-022-16905-w
PMID:35896583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9326423/
Abstract

There is an ongoing debate on the implementation of the COVID-19 passport throughout Europe. We sought to build and test a feasible prevention strategy to ensure low SARS-CoV transmission risk in public events. We conducted a non-randomised controlled study. The intervention group obtained a confidential digital certificate of very low capacity for transmitting SARS-CoV-2 and attended socio-cultural events in Girona (Spain) between 1 April and 21 May 2021. The primary care services and a network of pharmacies cooperated in providing the certification. A group of non-attendees was randomly selected from pseudonymised health records as controls. We estimated the incidences of SARS-CoV-2 infection and recorded the challenges in the process. Follow-up was complete for 1351 participants, who were matched with 4050 controls. Mean age of the study population was 31.1 years, and 53% of participants were women. Incidence rates of SARS-CoV infection at 14 days in the group of attendees and non-attendees were 15.9 and 17.7 per 100,000 person-days, respectively; the difference between incidences was - 1.8 (95% CI - 22.8, 19.3). Implementation problems were minor, and 89.2% of respondents to a survey were satisfied with the process. The incidence rate of SARS-CoV-2 infection was not different in the intervention and control groups. These results are in favour of establishing a COVID-19 certificate to attend public events, and connote feasibility of implementation at a population level.

摘要

在欧洲,关于实施 COVID-19 护照的问题一直存在争议。我们试图建立和测试一种可行的预防策略,以确保在公共活动中传播 SARS-CoV 的风险较低。我们进行了一项非随机对照研究。干预组获得了一份机密的数字证书,证明其传播 SARS-CoV-2 的能力非常低,并于 2021 年 4 月 1 日至 5 月 21 日在西班牙赫罗纳参加了社会文化活动。初级保健服务和一个网络药店合作提供认证。从假名健康记录中随机选择了一组未参加者作为对照组。我们估计了 SARS-CoV-2 感染的发病率,并记录了过程中的挑战。对 1351 名参与者进行了完整的随访,他们与 4050 名对照者相匹配。研究人群的平均年龄为 31.1 岁,53%的参与者为女性。在参与者和未参与者中,14 天的 SARS-CoV 感染发生率分别为每 100000 人天 15.9 和 17.7;发病率差异为-1.8(95%CI-22.8,19.3)。实施过程中出现的问题较小,对调查的 89.2%的受访者对该过程表示满意。干预组和对照组的 SARS-CoV-2 感染发病率无差异。这些结果支持建立 COVID-19 证书以参加公共活动,并暗示在人群层面上实施的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f4/9329400/aedcd63e4dcf/41598_2022_16905_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f4/9329400/b2d030fe8bd2/41598_2022_16905_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f4/9329400/aedcd63e4dcf/41598_2022_16905_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f4/9329400/b2d030fe8bd2/41598_2022_16905_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5f4/9329400/aedcd63e4dcf/41598_2022_16905_Fig2_HTML.jpg

相似文献

1
SARS-CoV-2 transmission risk screening for safer social events: a non-randomised controlled study.SARS-CoV-2 传播风险筛查以确保社交活动更安全:一项非随机对照研究。
Sci Rep. 2022 Jul 27;12(1):12794. doi: 10.1038/s41598-022-16905-w.
2
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD015112. doi: 10.1002/14651858.CD015112.pub3.
3
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
4
Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.工作场所干预措施以降低医疗机构外 SARS-CoV-2 感染的风险。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD015112. doi: 10.1002/14651858.CD015112.pub2.
5
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验(SAINT)评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力:一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.
6
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
7
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.一项评估褪黑素预防高危接触者 SARS-CoV-2 感染有效性的随机多中心临床试验(MeCOVID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):466. doi: 10.1186/s13063-020-04436-6.
8
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
9
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
10
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.羟氯喹用于接触新冠病毒疾病(COVID-19)后成年人暴露者预防严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的暴露后预防效果:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4.

引用本文的文献

1
Airborne infections related to virus aerosol contamination at indoor cultural venues: Recommendations on how to minimize.室内文化场所中与病毒气溶胶污染相关的空气传播感染:关于如何将其降至最低的建议。
Public Health Chall. 2023 Jan 20;2(1):e59. doi: 10.1002/puh2.59. eCollection 2023 Mar.
2
Implementing SARS-CoV-2 Testing during a Large-Scale Sporting Event in Africa: Lessons Learned from the Africa Football Cup of Nations Tournament in Cameroon.在非洲大型体育赛事期间开展严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测:喀麦隆非洲国家杯足球赛的经验教训
Am J Trop Med Hyg. 2024 Nov 26;112(4_Suppl):99-108. doi: 10.4269/ajtmh.23-0898. Print 2025 Apr 1.
3

本文引用的文献

1
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial.在大型室内聚集活动中预防 SARS-CoV-2 传播(SPRING):一项非劣效性、随机、对照试验。
Lancet Infect Dis. 2022 Mar;22(3):341-348. doi: 10.1016/S1473-3099(21)00673-3. Epub 2021 Nov 26.
2
The COVID-19 Pandemic and Mental Health Symptoms Among US Adults.美国成年人中的新冠疫情与心理健康症状
J Gen Intern Med. 2021 Oct;36(10):3285-3288. doi: 10.1007/s11606-021-07046-3. Epub 2021 Jul 27.
3
Screening for SARS-CoV-2 Antigen Before a Live Indoor Music Concert: An Observational Study.
Assessing the impact of COVID-19 passes and mandates on disease transmission, vaccination intention, and uptake: a scoping review.
评估 COVID-19 通行证和授权对疾病传播、疫苗接种意愿和接种率的影响:范围综述。
BMC Public Health. 2023 Nov 17;23(1):2279. doi: 10.1186/s12889-023-17203-4.
4
Lessons Learned from In-Person Conferences in the Times of COVID-19.新冠疫情时期的线下会议之教训。
Int J Environ Res Public Health. 2022 Dec 28;20(1):510. doi: 10.3390/ijerph20010510.
在室内现场音乐会前进行新冠病毒抗原检测:一项观察性研究。
Ann Intern Med. 2021 Oct;174(10):1487-1488. doi: 10.7326/M21-2278. Epub 2021 Jul 20.
4
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.BNT162b2 和 mRNA-1273 疫苗对新冠病毒的预防和衰减作用。
N Engl J Med. 2021 Jul 22;385(4):320-329. doi: 10.1056/NEJMoa2107058. Epub 2021 Jun 30.
5
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial.在室内大型聚集性现场音乐活动中进行 SARS-CoV-2 抗原同日检测筛查:一项随机对照试验。
Lancet Infect Dis. 2021 Oct;21(10):1365-1372. doi: 10.1016/S1473-3099(21)00268-1. Epub 2021 May 27.
6
Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test.自行采集的鼻腔拭子与专业采集的鼻咽拭子用于世界卫生组织清单上的 SARS-CoV-2 抗原检测快速诊断检测的头对头性能比较。
Med Microbiol Immunol. 2021 Aug;210(4):181-186. doi: 10.1007/s00430-021-00710-9. Epub 2021 May 24.
7
SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason.2020 常规赛和季后赛期间,接触过 COVID-19 康复后检测结果呈阳性个体的 NBA 球员、工作人员和供应商的 SARS-CoV-2 传播风险。
JAMA Intern Med. 2021 Jul 1;181(7):960-966. doi: 10.1001/jamainternmed.2021.2114.
8
Tourism and Sustainability in Times of COVID-19: The Case of Spain.新冠疫情时期的旅游与可持续发展:以西班牙为例。
Int J Environ Res Public Health. 2021 Feb 14;18(4):1859. doi: 10.3390/ijerph18041859.
9
Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.明确严重急性呼吸综合征冠状病毒2(SARS-CoV-2)抗原快速检测在新冠疫情(COVID-19)公共卫生应对中的证据。
Lancet. 2021 Apr 17;397(10283):1425-1427. doi: 10.1016/S0140-6736(21)00425-6. Epub 2021 Feb 17.
10
Rapid coronavirus tests: a guide for the perplexed.快速冠状病毒检测:给困惑者的指南。
Nature. 2021 Feb;590(7845):202-205. doi: 10.1038/d41586-021-00332-4.